The current study explored the acoustic and perceptual effects of speaking rate adjustments in persons with amyotrophic lateral sclerosis (ALS) and in neurologically normal individuals. Sentence utterances were obtained from the participants at two self-selected speaking rates: habitual and fast. Total utterance durations, segment durations, and vowel formant frequencies comprised the acoustic measures, whereas magnitude estimates of speech intelligibility and severity of speech involvement were the perceptual measures. Results showed that participants in both the neurologically normal and ALS groups were able to increase their speaking rate when asked to do so, but that the participants with ALS were significantly slower than the neurologically normal participants at both rates. Both groups of participants also showed compression of the acoustic vowel space with increased speaking rate, with the vowel spaces of participants with ALS generally being more compressed than the vowel spaces of neurologically normal participants, at either rate. Most importantly, the perceptual measures failed to show any effect of the speaking rate adjustment on scaled intelligibility or severity, for either group. These findings are discussed relative to the general issue of slow habitual speaking rates among many speakers with dysarthria, and possible explanations for the slowness. The lack of an effect of increased rate on the perception of the speech deficit among speakers with ALS argues against the idea that the habitually slow rates are a form of compensation to reduce the complexity of speech production.

Keywords:
Dysarthria, Vowel space, Acoustics, Intelligibility, Speaking rate
This content is only available via PDF.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.